We created the following three practical tools for physicians and medical personnel for their daily work in the ICU related to COVID-19 and sepsis.
- Recommendations for Vasoactive Management for Hemodynamic Support in COVID-19 Patients with Septic Shock
- SOFA Score
- WHO Categorization of Clinical Syndromes Associated with COVID-19 in Adults
Recommendations for Vasoactive Management for Hemodynamic Support in COVID-19 Patients with Septic Shock
In March 2020, the Surviving Sepsis Campaign published new therapy guidelines for the treatment of critically ill adult patients with Coronavirus(COVID-19) Based on these guidelines, we have summarized the recommendations specifically related to the vasoactive management for hemodynamic support in COVID-19 patients with septic shock on an A3 poster.
The SOFA-Score is a medical evaluation system, which is used to assess the degree of organ dysfunction, and consequently the mortality risk, of patients in intensive care units.1 SOFA stands for Sequential Organ Failure Assessment. We also offer this evaluation scale on an A3 poster for printing for assistance in the intensive care unit.
WHO Categorization of Clinical Syndromes Associated with COVID-19 in Adults
In March 2020, the World Health Organization (WHO) published interim guidelines for the Clinical Management of Severe Acute Respiratory Infection when COVID-19 is Suspected. In this document, the WHO outlined clinical syndromes associated with COVID-19. We have summarized these guidelines for adult patients on an A3 poster, which is also available for printing and can be used as an overview in the intensive care unit.
AMOMED‘s Offer for Intensive Care Medicine for COVID-19 Patients
The current COVID 19 outbreak has become an enormous challenge for hospitals and medical staff. In this exceptional situation, AMOMED Pharma offers support with pharmaceutical products for intensive care, including for septic shock, which can lead to dangerous complications for COVID-19 patients. Learn more or register here to gain access to our AmoMED Academy for studies and product insights. You can also contact us at [email protected] or +43 1 545 01 130. We are happy to answer any questions you may have.
1Quelle: DocCheck Flexikon